lexicon pharmaceuticals fda approval：LEXICON ANNOUNCES FDA APPROVAL OF INPEFA ...
LEXICON ANNOUNCES FDA APPROVAL OF INPEFA ...
2023年5月31日—(Nasdaq:LXRX)todayannouncedthattheU.S.FoodandDrugAdministration(FDA)hasapprovedINPEFA™(sotagliflozin),aonce-dailyoraltablet ...。其他文章還包含有：「AfterFDAMissinDiabetes」、「LexiconAnnouncesFDAApprovalofINPEFA™...」、「LexiconfinallyscoresFDAnodforheartfailuredrugInpefa」、「LexicongetsFDAapprovalforInpefatotreatheartfailure」、「LexiconPharmaSecuresKeyFDAApproval」、「U.S.FDA...
查看更多 離開網站
After FDA Miss in Diabetes
https://medcitynews.com
Lexicon Pharmaceuticals drug Inpefa is now FDA-approved for heart failure. Inpefa is third in its class, but the biotech says its pill can reach ...
Lexicon Announces FDA Approval of INPEFA™ ...
https://www.globenewswire.com
(Nasdaq: LXRX) today announced that the U.S. Food and Drug Administration (FDA) has approved INPEFA™ (sotagliflozin), a once-daily oral tablet ...
Lexicon finally scores FDA nod for heart failure drug Inpefa
https://www.fiercepharma.com
After setbacks, Lexicon's SGLT1/SGLT2 inhibitor Inpefa has gained an FDA approval to reduce the risk of heart failure.
Lexicon gets FDA approval for Inpefa to treat heart failure
https://www.pharmaceutical-tec
Lexicon Pharma Secures Key FDA Approval
https://seekingalpha.com
Lexicon Pharmaceuticals received FDA approval to market its heart failure drug Inpefa, as well as a broad label compared to rivals like ...
U.S. FDA approves Lexicon Pharma's drug for heart failure
https://www.reuters.com
The oral drug, sotagliflozin, is the company's first to be approved by the U.S. health agency and will be sold under the brand name Inpefa. It ...
UPDATE
https://www.globenewswire.com
(Nasdaq: LXRX) today announced that the U.S. Food and Drug Administration (FDA) has approved INPEFA™ (sotagliflozin), a once-daily oral tablet ...
US FDA approves Lexicon Pharma's drug for heart failure
https://health.economictimes.i
US FDA approves Lexicon Pharma's drug for heart failure. The oral drug, sotagliflozin, is the company's first to be approved by the US health ...